Recursion Pharmaceuticals Inc vs Vital Farms Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B), while Vital Farms Inc trades at $11.39 (market cap $496.50M). The key difference: Recursion Pharmaceuticals Inc is far larger — about 3.6× Vital Farms Inc's market cap. Which is the better fit depends on your goals.
| RXRX | VITL | |
|---|---|---|
Market Cap | $1.81B | $496.50M |
Sector | Health | Consumer Staples |
52-Week High | $6.79 | $52.41 |
52-Week Low | $2.84 | $8.28 |
Enterprise Value | $1.33B | $583.51M |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →